Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is E  [Clear All Filters]
2024
Al-Hamoud A, Pansu N, Brun A-L, Etienne N, Farfour E, Avettand-Fenoel V, Rouzaud C, Roux A, Suarez F, Salvator H, et al. Determinants of radiological patterns and severity in immunocompromised adults with Metapneumovirus infection. Respir Med. 2024:107604.
S BGanesh, Sabu A, Kaarthikeyan G, Eswaramoorthy R, T PP. Development of a Cissus quadrangularis-Doped Extracellular Matrix and a Hyaluronic Acid-Incorporated Scaffold for Periodontal Regeneration: An In Vitro Study. Cureus. 2024;16(3):e56507.
Cunha AB, Schuelke C, Mesri A, Ruud SK, Aizenshtadt A, Ferrari G, Heiskanen A, Asif A, Keller SS, Ramos-Moreno T, et al. Development of a Smart Wireless Multisensor Platform for an Optogenetic Brain Implant. Sensors (Basel). 2024;24(2).
Gold MP, Ong W, Masteller AM, Ghasemi DR, Galindo JAnne, Park NR, Huynh NC, Donde A, Pister V, Saurez RA, et al. Developmental basis of SHH medulloblastoma heterogeneity. Nat Commun. 2024;15(1):270.
Aiello TFrancesco, Salmanton-García J, Marchesi F, Weinbergerova B, Glenthoj A, van Praet J, Farina F, Dávila-Valls J, Martín-Pérez S, El-Ashwah S, et al. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica. 2024.
Aiello TFrancesco, Salmanton-García J, Marchesi F, Weinbergerova B, Glenthoj A, van Praet J, Farina F, Dávila-Valls J, Martín-Pérez S, El-Ashwah S, et al. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica. 2024.
Aiello TFrancesco, Salmanton-García J, Marchesi F, Weinbergerova B, Glenthoj A, van Praet J, Farina F, Dávila-Valls J, Martín-Pérez S, El-Ashwah S, et al. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica. 2024.
Aiello TFrancesco, Salmanton-García J, Marchesi F, Weinbergerova B, Glenthoj A, van Praet J, Farina F, Dávila-Valls J, Martín-Pérez S, El-Ashwah S, et al. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica. 2024.
Aiello TFrancesco, Salmanton-García J, Marchesi F, Weinbergerova B, Glenthoj A, van Praet J, Farina F, Dávila-Valls J, Martín-Pérez S, El-Ashwah S, et al. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica. 2024.
Aiello TFrancesco, Salmanton-García J, Marchesi F, Weinbergerova B, Glenthoj A, van Praet J, Farina F, Dávila-Valls J, Martín-Pérez S, El-Ashwah S, et al. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica. 2024.
Hägele P, Staus P, Scheible R, Uhlmann A, Heeg M, Klemann C, Maccari MElena, Ritterbusch H, Armstrong M, Cutcutache I, et al. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study. Lancet Haematol. 2024;11(2):e114-e126.
Hägele P, Staus P, Scheible R, Uhlmann A, Heeg M, Klemann C, Maccari MElena, Ritterbusch H, Armstrong M, Cutcutache I, et al. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study. Lancet Haematol. 2024;11(2):e114-e126.
Manafi-Farid R, Mahini M, Mirshahvalad SAli, Fallahi B, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M, Mousavi SAsadollah, Beiki D. Diagnostic value of [68Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study. Nucl Med Commun. 2024.
Manafi-Farid R, Mahini M, Mirshahvalad SAli, Fallahi B, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M, Mousavi SAsadollah, Beiki D. Diagnostic value of [68Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study. Nucl Med Commun. 2024.
Huang W, Das NK, Radyk MD, Keeley T, Quirós M, Jain C, El-Derany MO, Swaminathan T, Dziechciarz S, Greenson JK, et al. Dietary iron is necessary to support proliferative regeneration following intestinal injury. J Nutr. 2024.
Esfahani ATorshizi, Mohammadpour S, Jalali P, Yaghoobi A, Karimpour R, Torkamani S, Pardakhtchi A, Salehi Z, Nazemalhosseini-Mojarad E. Differential expression of angiogenesis-related genes 'VEGF' and 'angiopoietin-1' in metastatic and EMAST-positive colorectal cancer patients. Sci Rep. 2024;14(1):10539.
Reho P, Saez-Atienzar S, Ruffo P, Solaiman S, Shah Z, Chia R, Kaivola K, Traynor BJ, Tilley BS, Gentleman SM, et al. Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodies. Commun Biol. 2024;7(1):35.
Ertem T, Uysal O. Differentiation of neural stem cells from human olfactory mucosa into dopaminergic neuron-like cells. IUBMB Life. 2024.
Hashemi SMohammad J, Enderami SEhsan, Barzegar A, Mansour RNassiri. Differentiation of Wharton's Jelly-derived mesenchymal stem cells into insulin-producing beta cells with the enhanced functional level on electrospun PRP-PVP-PCL/PCL fiber scaffold. Tissue Cell. 2024;87:102318.
Sharmin S, Roos I, Malpas CB, Iaffaldano P, Simone M, Filippi M, Havrdova EKubala, Ozakbas S, Morra VBrescia, Alroughani R, et al. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. Lancet Child Adolesc Health. 2024.
Minutti CM, Piot C, da Costa MPereira, Chakravarty P, Rogers N, Encabo HHuerga, Cardoso A, Loong J, Bessou G, Mionnet C, et al. Distinct ontogenetic lineages dictate cDC2 heterogeneity. Nat Immunol. 2024.
Weatherbee BAT, Weberling A, Gantner CW, Iwamoto-Stohl LK, Barnikel Z, Barrie A, Campbell A, Cunningham P, Drezet C, Efstathiou P, et al. Distinct pathways drive anterior hypoblast specification in the implanting human embryo. Nat Cell Biol. 2024.
Weatherbee BAT, Weberling A, Gantner CW, Iwamoto-Stohl LK, Barnikel Z, Barrie A, Campbell A, Cunningham P, Drezet C, Efstathiou P, et al. Distinct pathways drive anterior hypoblast specification in the implanting human embryo. Nat Cell Biol. 2024.
Espaillat A, Alvarez L, Torrens G, Beek JTer, Miguel-Ruano V, Irazoki O, Gago F, Hermoso JA, Berntsson RP-A, Cava F. A distinctive family of L,D-transpeptidases catalyzing L-Ala-mDAP crosslinks in Alpha- and Betaproteobacteria. Nat Commun. 2024;15(1):1343.
Zhang H, Song J, Ward R, Han Y, Hunt A, Shriwas P, Steed A, Edwards C, Cao Y, Co M, et al. Diverse temporal and spatial mechanisms work, partially through Stanniocalcin-1, V-ATPase and senescence, to activate the extracellular ATP-mediated drug resistance in human cancer cells. Front Oncol. 2024;14:1276092.

Pages